Beneficial effects of nifedipine on rest and exercise myocardial energetics in patients with congestive heart failure
- PMID: 6488501
- DOI: 10.1161/01.cir.70.5.884
Beneficial effects of nifedipine on rest and exercise myocardial energetics in patients with congestive heart failure
Abstract
Rest and exercise systemic hemodynamic parameters, coronary blood flow, and myocardial energetics were assessed before and 15 min after the sublingual administration of 20 mg of nifedipine in 10 patients with idiopathic congestive cardiomyopathy. When compared with control, nifedipine increased rest and exercise cardiac index by 37% and 28%, respectively (p less than .001). Peripheral vasodilation was demonstrated with a drop in systemic arterial pressure, exercise pulmonary capillary wedge pressure, and systemic vascular resistance (p less than .05). The calcium-channel blocker did not alter myocardial oxygen consumption; however, coronary blood flow increased by 32% at rest (p less than .01) while coronary vascular resistance diminished both at rest and after exercise compared with control (p less than .05). Nifedipine elicited a decrease in the rest and exercise aortocoronary sinus oxygen difference while the coronary sinus oxygen saturation increased (p less than .01). In this group of patients with idiopathic congestive cardiomyopathy, nifedipine enhanced myocardial performance while increasing coronary blood flow and favorably altering the myocardial oxygen supply-demand balance.
Similar articles
-
Arterial vasodilator, systemic and coronary hemodynamic effects of nisoldipine in congestive heart failure secondary to ischemic or dilated cardiomyopathy.Am J Cardiol. 1987 May 1;59(12):1118-25. doi: 10.1016/0002-9149(87)90859-9. Am J Cardiol. 1987. PMID: 3578053
-
Nifedipine in congestive heart failure: effects on resting and exercise hemodynamics and regional blood flow.Am Heart J. 1984 Dec;108(6):1461-8. doi: 10.1016/0002-8703(84)90693-8. Am Heart J. 1984. PMID: 6507242
-
[Hemodynamic responses to sublingual nifedipine during exercise and recovery in congestive heart failure].J Cardiol. 1990;20(4):991-9. J Cardiol. 1990. PMID: 2133733 Japanese.
-
Calcium channel blocking agents in congestive heart failure.Am J Med. 1986 Feb 28;80(2B):46-50. doi: 10.1016/0002-9343(86)90144-0. Am J Med. 1986. PMID: 3511695 Review. No abstract available.
-
Usefulness of calcium antagonists for congestive heart failure.Am J Cardiol. 1987 Jan 30;59(3):52B-58B. doi: 10.1016/0002-9149(87)90082-8. Am J Cardiol. 1987. PMID: 3544790 Review.
Cited by
-
Calcium channel antagonists. Part III: Use and comparative efficacy in hypertension and supraventricular arrhythmias. Minor indications.Cardiovasc Drugs Ther. 1988 Mar;1(6):625-56. doi: 10.1007/BF02125750. Cardiovasc Drugs Ther. 1988. PMID: 3154329 Review.
-
Calcium antagonists in patients with heart failure. A review.Drugs. 1991 Sep;42(3):343-64. doi: 10.2165/00003495-199142030-00002. Drugs. 1991. PMID: 1720378 Review.
-
The haemodynamic effects of nifedipine, verapamil and diltiazem in patients with coronary artery disease. A review.Drugs. 1986 Jul;32(1):66-101. doi: 10.2165/00003495-198632010-00004. Drugs. 1986. PMID: 2874975 Review.
-
Calcium antagonists and chronic cardiac failure.Postgrad Med J. 1986 Aug;62(730):713-7. doi: 10.1136/pgmj.62.730.713. Postgrad Med J. 1986. PMID: 3534840 Free PMC article. Review. No abstract available.
-
Vasodilator therapy without converting-enzyme inhibition in congestive heart failure--usefulness and limitations.Cardiovasc Drugs Ther. 1989 Jun;3(3):375-96. doi: 10.1007/BF01858109. Cardiovasc Drugs Ther. 1989. PMID: 2487535 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical